A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

被引:12
|
作者
Punga, Anna Rostedt [1 ]
Alimohammadi, Mohammad [2 ]
Fagrell, Dan [3 ]
Nyberg, Frida [4 ]
Rees, Diane [5 ]
Wong, Cindy [4 ]
机构
[1] Uppsala Univ, Dept Neurosci, Husargatan 3, S-75124 Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[3] Goteborgs Plastikkirurgiska Ctr, Gothenburg, Sweden
[4] Galderma A&C, Uppsala, Sweden
[5] Zenith Healthcare Commun Ltd, Chester, Cheshire, England
关键词
TOXIN TYPE-A; DOUBLE-BLIND; BOTULINUM; DIFFUSION; RHYTIDES;
D O I
10.1097/DSS.0000000000000805
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUNDDifferent volumes of 0.9% NaCl may be used to reconstitute abobotulinumtoxinA yielding an injection volume that ranges from 0.05 to 0.1 mL per injection point for treatment of glabellar lines.OBJECTIVETo evaluate the efficacy, safety, and subject satisfaction of 2 different injection volumes to deliver the same unit dose of abobotulinumtoxinA for treatment of glabellar lines.MATERIALS AND METHODSThis randomized comparative study was conducted using 2 different reconstitution volumes to deliver a fixed unit dose of 10 Speywood units (sU) of abobotulinumtoxinA in either 0.05 mL (labeled volume) or 0.1 mL (twofold volume) per injection point. Evaluations included wrinkle severity, neurophysiological assessment by compound muscle action potential (CMAP), and subject satisfaction.RESULTSUse of either injection volume of abobotulinumtoxinA resulted in the early onset of effect, high effectiveness, and long duration of effect. The safety profile and injection pain levels were similar in both groups. The twofold injection volume was shown to be noninferior to the labeled injection volume based on CMAP results.CONCLUSIONA twofold increase in injection volume to 0.1 mL per injection point to deliver 10 sU of abobotulinumtoxinA is effective and safe.
引用
收藏
页码:967 / 976
页数:10
相关论文
共 50 条
  • [21] Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
    Solish, Nowell
    Burgess, Cheryl M.
    Weinkle, Susan H.
    Ablon, Glynis
    Brown, Jessica
    Kooken, Kristie
    Rubio, Roman G.
    AESTHETIC SURGERY JOURNAL, 2023, 43 (02) : 205 - 214
  • [22] Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
    Dayan, Steven
    Joseph, John
    Moradi, Amir
    Lorenc, Z. Paul
    Coleman, Kyle
    Ablon, Glynis
    Kaufman-Janette, Joely
    Cox, Sue Ellen
    Campbell, Andrew
    Munavalli, Girish
    Prygova, Inna
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (06) : 2407 - 2416
  • [23] A Real-World Study of Patient and Physician Satisfaction With AbobotulinumtoxinA Treatment of Glabellar Lines in Chinese Patients
    Persson, Cecilia
    Huang, Jianmei
    Jiang, Zhongrong
    Ma, Li
    Zhao, Jingjing
    Xue, Zhiqiang
    Zhang, Shuxian
    Chen, Yuan
    Song, Weiming
    Tao, Lin
    Liu, Qingyang
    Prygova, Inna
    TOXICON, 2024, 237 : 70 - 70
  • [24] Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment of Upper Facial Lines
    Hexsel, Doris
    Cartier, Hugues
    Heden, Per
    Delmar, Henry
    Bergentz, Per
    Camozzato, Fernanda
    Siega, Carolina
    Skoglund, Cecilia
    Edwartz, Carolina
    Rees, Diane
    Kestemont, Philippe
    DERMATOLOGIC SURGERY, 2018, 44 (12) : 1555 - 1564
  • [25] Two phase 3, randomized, double-blind, placebo-controlled, multicenter trials to evaluate the efficacy and safety of daxibotulinumtoxinA for injection to treat moderate to severe glabellar lines (SAKURA 1 and 2)
    Solish, Nowell
    Bertucci, Vince
    Humphrey, Shannon
    Bhatia, Ashish
    Biesman, Brian
    Joseph, John
    Kaufman-Janette, Joely
    Glogau, Richard
    Park, Eric
    Rubio, Roman
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB306 - AB306
  • [26] Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-blind, Multicenter, Placebo-Controlled Phase 3 Study
    Mueller, Daniel S.
    Prinz, Valentina
    Adelglass, Jeffrey
    Cox, Sue Ellen
    Gold, Michael H.
    Kaufman-Janette, Joely
    Nestor, Mark S.
    Taylor, Susan
    Frank, Konstantin
    AESTHETIC SURGERY JOURNAL, 2022, 42 (06) : 677 - 688
  • [27] ESCALATING DOSES OF INCOBOTULINUMTOXINA FOR EXTENDED TREATMENT OF GLABELLAR FROWN LINES: SAFETY AND EFFICACY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND STUDY
    Maas, Corey
    TOXICON, 2018, 156 : S70 - S71
  • [28] A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines
    Carruthers, JA
    Lowe, NJ
    Menter, MA
    Gibson, J
    Nordquist, M
    Mordaunt, J
    Walker, P
    Eadie, N
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) : 840 - 849
  • [29] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines
    Carruthers, Jean
    Rivkin, Alexander
    Donofrio, Lisa
    Bertucci, Vince
    Somogyi, Chris
    Lei, Xiaofang
    Davis, Paula G.
    Campo, Antoinette
    Beddingfield, Frederick C.
    DERMATOLOGIC SURGERY, 2015, 41 (06) : 702 - 711
  • [30] Two-plane injection of botulinum toxin for the treatment of glabellar frown lines
    Ozsoy, Z
    Gözü, A
    Genç, B
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2002, 110 (01) : 371 - 372